Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
Clinical trial NCT03046862 · UNKNOWN
Trial details
- NCT number
- NCT03046862
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-25
- Primary completion
- 2020-05-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.